Core Insights - FMC reported $1.05 billion in revenue for the quarter ended June 2025, marking a year-over-year increase of 1.2% and an EPS of $0.69 compared to $0.63 a year ago, with revenue exceeding Zacks Consensus Estimate by +8.82% [1] - The EPS surprise was +16.95% over the consensus estimate of $0.59 [1] Financial Performance - FMC's shares have returned -7% over the past month, while the Zacks S&P 500 composite increased by +2.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3] Geographic Revenue Breakdown - Latin America: $310 million, exceeding the estimated $296.12 million, with a year-over-year change of +0.9% [4] - Europe, Middle East and Africa (EMEA): $260 million, surpassing the average estimate of $223.58 million, reflecting a +29.2% year-over-year increase [4] - Asia: $159 million, slightly below the estimated $163.72 million, showing a year-over-year decline of -16.8% [4] - North America: $321 million, above the estimated $294.07 million, but representing a -5.3% year-over-year change [4] Revenue by Product - Insecticides: $525.3 million, exceeding the estimated $487.74 million, but down -7.7% year-over-year [4] - Fungicides: $80.4 million, surpassing the average estimate of $67.79 million, with a +7.9% year-over-year increase [4] - Herbicides: $376 million, exceeding the estimated $323.09 million, reflecting a +11.7% year-over-year change [4]